Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TetraQ was an Australia-based preclinical contract research organization focused on toxicology, bioanalytical, ADME, efficacy, and pharmaceutics services for biotechnology and pharmaceutical clients. Originating from the University of Queensland in 2005, it developed a strong reputation for GLP-compliant rodent toxicology and related preclinical drug development support. The business operated as a NATA-accredited, GLP-recognised facility supporting first-in-human enabling studies and broader outsourced R&D needs. In April 2021, TetraQ was acquired by Agilex Biolabs, and its toxicology capabilities were incorporated into Agilex's service offering. As a result, TetraQ no longer appears to operate as an independent active company brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TetraQ Toxicology.